<!DOCTYPE html>

<html lang="fa">
<meta content="text/html;charset=utf-8" http-equiv="content-type"/>
<head><title>Apoptosis and autoimmune disease</title><link href="/z/d/css/bootstrap.min.css" rel="stylesheet"/><link href="/z/d/css/icofont.min.css" rel="stylesheet"/><link href="/z/d/css/classy-nav.min.css" rel="stylesheet"/><link href="/z/d/css/animate.css" rel="stylesheet"/><link href="/z/d/css/owl.carousel.css" rel="stylesheet"/><link href="/z/d/css/magnific-popup.css" rel="stylesheet"/><link href="/z/d/css/owl.theme.default.min.css" rel="stylesheet"/><link href="/z/d/css/style.css" rel="stylesheet"/><link href="/z/d/css/rtl_edited.css" rel="stylesheet"/><link href="/z/d/css/responsive.css" rel="stylesheet"/><link href="https:///uptodate_assets/main.css" rel="stylesheet"/>
<style>

#myUL {
  list-style-type: none;
  padding: 0;
  margin: 0;
}

#myUL li a {
  border: 1px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #f6f6f6;
  padding: 12px;
  text-decoration: none;
  font-size: 16px;
  color: black;
  display: block
}

#myUL li a:hover:not(.header) {
  background-color: #eee;
}

#searchResult {

  list-style-type: none;
  padding: 0;
  padding-right: 20px;
}

#searchResult li a {
  border: .5px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #79bc21;
  padding: 7px;
  text-decoration: none;
  font-size: 14px;
  color: white;
  display: block
}

#searchResult li a:hover:not(.header) {
  background-color: #222;
}


#txtHint   {
  position: absolute;
  text-shadow: none;
  width: 100%;
  margin-top: -15px;
  padding-right: 10px;

  filter: alpha(opacity=95);
  -moz-opacity: 0.95;
  opacity: 1;
  z-index: 200;
}
.countBubl {
  background:#eb0029;
  color:#fff;
  padding:5px;
  margin-top: 50%;

}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(2) {
 width: 55%;
 padding-left: 20px;
}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(3) {
 width: 20%;
}
 #Uptodate_image {
      width: 50%;
  }#uptodate-area {
      /*z-index: 99;*/
  }
#uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > div:nth-child(2) {
 margin-left: 10px;
 margin-bottom: 6%;
}
@media (max-width: @screen-xs) {
    .countBubl {
        font-size: 4px ;
    }
    #uptodate_version {
        font-size: 4px ;
    }
}

@media (max-width: @screen-sm) {
    .countBubl {
        font-size: 14px ;
    }
}
@media  all and(max-width: 820) {
    #Uptodate_image {
        width: 80% ;
    }#uptodate-area {
        z-index: 99;
    }
}@media  all and (min-width: 820) and(max-width: 88820){
    #Uptodate_image {
        width: 100% !important;
    }
    .countBubl {
        font-size: 4px ;
    }
}
div.col-md-3:nth-child(3) {
 margin-top: 6%;
}

div.col-md-3:nth-child(3) > img:nth-child(1) {
 width: 100%;
 margin-left: 11px;
}

</style>
<style media="screen" type="text/css">
  .goback {
    width: 200px;
    height: 40px;
    line-height: 40px;
    position: fixed;
    display: none;
    font-size: 15px;
    background: #71c0fa;
    z-index: 1000;
    text-align: center;
    color: #ffffff;
    -webkit-border-radius: 1px;
    -moz-border-radius: 1px;
    border-radius: 50px;
    bottom: 3.8%;
    right: 2%;
}
  .buyPackage {
  width: 100px;
  height: 100px;
  line-height: 40px;
  position: fixed;
  display: none;
  font-size: 10px;
  background: #fa759e;
  z-index: 1000;
  text-align: center;
  color: #ffffff;
  -webkit-border-radius: 1px;
  -moz-border-radius: 1px;
  border-radius: 10px;
  top: 150px;
  right: 2%;
  text-align: center;
}
.uptodate-area {
  /*background-image: url(../../assets/img/news-letter-bg.jpg);*/
  background-position: center center;
  background-size: cover;
  background-repeat: no-repeat;
    background-attachment: fixed;
  position: relative;
}
.uptodate-area::before {
  content: '';
  position: absolute;
  left: 0;
  padding-top: 100px;
  width: 100%;
}
#references{
  display: none;
}
</style>
<style>
section.sticky {
  position: sticky;
  top: 0;
  background-color: #fff !important;
  /*z-index: 100;*/
  /*padding-top: 80px;*/

}
.m4inb{
    border: solid !important;
  }

  .newsletter-area::before {
       background: unset !important;
  }
p {
    color: #555;
}
</style>
<meta content="" name="description"/>
<link href="/z/d/img/favicon.png" rel="icon" type="image/png">
</link></head>
<body>
<!-- Start Main Menu Area -->
<br/>
<br/>
<br/>
<br/>
<div class="container">
<div class="row">
</div>
</div>
<section class="teacher-area ptb-10">
<div class="container">
</div>
<section class="course-details-area ptb-60">
<div class="container">
<div class="uptodate2" style="padding:50px 0px 50px 0px;direction: ltr;text-align: left;">
<h1 style="text-align:center">Apoptosis and autoimmune disease</h1>
<div class="utdArticleSection utdStyle" id="topicContent"><div id="topicTitle">Apoptosis and autoimmune disease</div> <div class="authorSectionElem"><div class="authorsElementsLeft"><dl id="topicContributors"><dt><span> </span>Author:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Keith Elkon, MD</a></dd><dt><span> </span>Section Editors:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Peter H Schur, MD</a></dd><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">William FC Rigby, MD</a></dd><dt><span> </span>Deputy Editor:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Siobhan M Case, MD, MHS</a></dd></dl></div><div class="authorsElementsRight"><div id="literatureReviewDate"><div class="litReviewSingleLine"><bdi><span class="emphasis">Literature review current through:</span> Jan 2024.</bdi></div><div class="litReviewSingleLine"><bdi><span class="emphasis">This topic last updated:</span> Jun 15, 2023.</bdi></div></div></div></div><div id="topicWhatsNewContainer"></div><div id="topicText"><p class="headingAnchor" id="H1"><span class="h1">INTRODUCTION</span><span class="headingEndMark"> — </span>Apoptosis refers to cell death that occurs in a programmed manner, is characterized by cellular condensation (<a class="graphic graphic_figure graphicRef71513" href="/z/d/graphic/71513.html" rel="external">figure 1</a>), and is noninflammatory or even antiinflammatory through the induction of certain cytokines and generation of T regulatory cells. By these criteria, it differs from necrosis, which is often referred to as "accidental" or pathologic death and which is accompanied by cell swelling (<a class="graphic graphic_figure graphicRef71513" href="/z/d/graphic/71513.html" rel="external">figure 1</a>) and inflammation. These processes and their relationship to autoimmunity have been the subject of detailed investigation [<a href="#rid1">1</a>].</p><p>Apoptosis plays a pivotal role in the following processes [<a href="#rid2">2,3</a>]:</p><p class="bulletIndent1"><span class="glyph">●</span>Morphogenesis and tissue remodeling during embryonic development</p><p class="bulletIndent1"><span class="glyph">●</span>Cell death associated with homeostatic control of cell numbers (eg, immune system, lungs, skin, gastrointestinal tract)</p><p class="bulletIndent1"><span class="glyph">●</span>Elimination of immune effector cells that proliferate in response to activation (eg, by microbial infection)</p><p></p><p>The morphological features of apoptosis have been appreciated for decades: cytoplasmic and nuclear condensation, incorporation of intracellular constituents into membrane-enclosed "apoptotic bodies" that may bud from the surface, and surface expression of opsonic receptors that allow cells to rapidly phagocytose and to digest the corpse [<a href="#rid4">4</a>]. A key feature of this physiologic death process is the preservation of plasma membrane integrity. Rapid ingestion of the apoptotic corpse by phagocytes with continued digestion of the cellular constituents prevents the cell from undergoing post-apoptotic necrosis associated with rupture of the membrane and extrusion of the cell contents [<a href="#rid5">5</a>].</p><p>In addition, it has been determined that cells may also die by specialized forms of necrosis that are also programmed. Examples include NETosis, a term for neutrophil extracellular trap (NET)-mediated cell death, as well as necroptosis and pyroptosis. The last two forms of cell death are associated with release of inflammatory cytokines such as interleukin (IL) 6 (necroptosis) or IL-1beta (pyroptosis) and could therefore be crucially involved in autoinflammatory and autoimmune diseases (see <a class="local">'Clinical correlations'</a> below). An outline of the biochemical pathways for each of these proinflammatory forms of cell death has been described [<a href="#rid1">1</a>].</p><p>Autophagy is a catabolic process by which cellular components are consumed and recycled and is not per se a mechanism of cell death. Autophagy has, however, been observed to accompany cell death induced by nutrient starvation. It has a characteristic morphology associated with the formation of autophagosomes [<a href="#rid6">6</a>], and it will not be considered further here.</p><p>The relationship between apoptosis, as well as other forms of cell death, and autoimmune disease, is discussed in this topic review.</p><p class="headingAnchor" id="H2"><span class="h1">MOLECULAR MECHANISMS OF APOPTOSIS</span><span class="headingEndMark"> — </span>The biochemical pathways responsible for apoptotic cell death have been elucidated in some detail. A genetic framework for the core death program has been provided by studies of the roundworm, <em>Caenorhabditis elegans</em> [<a href="#rid7">7,8</a>].</p><p class="headingAnchor" id="H3"><span class="h2">Caenorhabditis elegans</span><span class="headingEndMark"> — </span>Microscopic observations of <em>C. elegans</em>, a translucent nematode, have identified a subset of cells destined to die by apoptosis. Chemical mutagenesis has allowed the identification of genes that regulate this process.</p><p>Ced-3 is a downstream effector of the apoptotic program (<a class="graphic graphic_figure graphicRef73569" href="/z/d/graphic/73569.html" rel="external">figure 2</a>). It is activated by ced-4, which is inhibited by ced-9. In turn, ced-9 is inhibited by egl-1. It follows from this scheme that the expression or activation of egl-1 results in apoptotic cell death. A number of different ced genes also encode proteins responsible for phagocytosis of apoptotic cells (<a class="graphic graphic_figure graphicRef58618" href="/z/d/graphic/58618.html" rel="external">figure 3</a>).</p><p class="headingAnchor" id="H4"><span class="h2">Higher eukaryotes</span><span class="headingEndMark"> — </span>Although the genetic blueprint utilized by <em>C. elegans</em> is followed in higher eukaryotes, the situation is complicated by the expression of multiple genes that correspond to each step delineated in the nematode (<a class="graphic graphic_figure graphicRef58618" href="/z/d/graphic/58618.html" rel="external">figure 3</a>):</p><p class="bulletIndent1"><span class="glyph">●</span>Just as ced-3 is a downstream effector of apoptosis in <em>C. elegans</em>, ced-3 orthologs comprise a family of proteases called caspases in higher eukaryotes. Caspases digest structural and enzymatic constituents of the cell to bring about apoptotic death [<a href="#rid9">9</a>]. Not all caspases are involved in the execution of apoptosis. Human caspases 1, 4, 5, and possibly 12 and mouse caspases 1, 4, 11, and 12 are involved in promoting inflammation.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>The ced-4 orthologs (apoptosis activating factors [APAFs]) bind to the caspases and facilitate their conversion from inactive zymogens to active proteases.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>The ced-9 and egl-1 orthologs comprise a large family of proteins related to B-cell leukemia/lymphoma 2 (Bcl-2) [<a href="#rid10">10</a>], an oncogene that is transcriptionally activated by the t(14;18) chromosome translocation found in B-cell follicular lymphomas (see  <a class="medical medical_review" href="/z/d/html/4699.html" rel="external">"Clinical manifestations, pathologic features, diagnosis, and prognosis of follicular lymphoma"</a>). Overexpression of Bcl-2 inhibits apoptosis in these cells, an essential component of lymphomatous growth. Individual members of the Bcl-2 family can interact with one another either to promote or to inhibit apoptosis, just as ced-9 prevents cell death and as egl-1 promotes cell death (by preventing the function of ced-9) [<a href="#rid11">11</a>].</p><p></p><p class="headingAnchor" id="H5"><span class="h3">Triggering apoptosis</span><span class="headingEndMark"> — </span>In higher eukaryotes, the core death program can be triggered from without (external or extrinsic) or from within (internal or intrinsic) the cell [<a href="#rid12">12</a>]:</p><p class="bulletIndent1"><span class="glyph">●</span>External triggering involves the ligation of dedicated death receptors by soluble or cell-associated ligands [<a href="#rid3">3</a>].</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Internal triggering occurs when cells respond to environmental stress (eg, heat, x-rays, ultraviolet irradiation), to deoxyribonucleic acid (DNA) damage (genotoxic injury), or to misfolded proteins (endoplasmic stress). These events alter the function of mitochondria, an organelle that is essential not only for cell survival through the generation of adenosine triphosphate (ATP) but also for the regulation of entry into cell death [<a href="#rid13">13</a>].</p><p></p><p>Examples of extrinsic and intrinsic triggers of apoptosis are depicted schematically in the figure (<a class="graphic graphic_figure graphicRef61795" href="/z/d/graphic/61795.html" rel="external">figure 4</a>). In this example, ligation of the dedicated death receptors CD95 (Fas) or tumor necrosis factor-receptor type I (TNF-RI) results in the recruitment of adaptor molecules (eg, Fas-associated protein with death domain [FADD] and tumor necrosis factor receptor type I-associated death domain protein [TRADD]) [<a href="#rid14">14,15</a>].</p><p class="headingAnchor" id="H6"><span class="h3">Proteolytic cascade</span><span class="headingEndMark"> — </span>The adaptor molecules subsequently bind both to the cytoplasmic domain of the dedicated death receptor and to the inactive form of caspase-8, an "upstream" caspase that initiates a proteolytic cascade leading to cell death. Because the zymogenic form of caspase-8 possesses low levels of protease activity, its aggregation induces conformational changes that allow proteolytic cleavage of an adjacent molecule, thereby initiating the proteolytic cascade. This culminates in the activation of effector caspases (eg, caspase-3) which directly cleave structural proteins (eg, nuclear lamins and cytoskeletal gelsolins) and enzymes, such as the inhibitor of caspase-activated DNase (ICAD). Cleavage of ICAD leads to the release of active CAD, which enters the nucleus and cleaves nucleosomes at the linker region, yielding the characteristic "DNA ladder." The end result is apoptotic death of the cell.</p><p>In response to environmental stress or cell damage (<a class="graphic graphic_figure graphicRef60345" href="/z/d/graphic/60345.html" rel="external">figure 5</a>), the BH3 members of the Bcl-2 family such as Bak and Bax alter the permeability of the outer mitochondrial membrane, resulting in the release of cytochrome C and other effector proteins. Cytochrome C is a cofactor that allows APAF-1 to promote the activation of caspase-9, an "upstream" caspase that is essential for initiation of the intrinsic death program; the subsequent activation of effector proteases, including caspase-3, results in apoptotic cell death [<a href="#rid16">16</a>].</p><p>These basic pathways that lead to apoptosis are regulated by several proteins that bind to death receptors, adaptors, or caspases to modulate their function. Examples include Bcl-2 family members that titrate each other [<a href="#rid17">17,18</a>] and may bind to APAFs; inhibitors of apoptosis (IAPs), some of which attenuate caspase activity [<a href="#rid19">19</a>]; as well as the PI-3 Akt pathway that activates NFk-B and also blocks death effectors [<a href="#rid20">20</a>]. Not surprisingly, entry into apoptosis is a highly regulated process.</p><p class="headingAnchor" id="H7"><span class="h2">Noninflammatory phagocytosis</span><span class="headingEndMark"> — </span>One of the hallmarks of apoptosis is that cells undergoing programmed death are phagocytosed by macrophages and dendritic cells and promote an antiinflammatory immune response through induction of the cytokines, transforming growth factor (TGF)-beta or interleukin (IL) 10 [<a href="#rid5">5</a>]. Phagocytosis is, in part, triggered by the expression of phosphatidylserine on the dying cell surface which, in turn, is recognized directly either by cell surface receptors or by opsonins (bridging molecules), which link the apoptotic cells with phagocytes [<a href="#rid12">12</a>]. The efficiency of the phagocytic process depends upon the presence of the opsonins that include normal serum components such as the complement proteins C1q, C3, C4, and members of the pentraxin family, including pentraxin-3 (PTX3) and C-reactive protein (CRP) [<a href="#rid21">21,22</a>]. Binding of protein S, an antithrombotic plasma protein, to phosphatidylserine on the surface of apoptotic cells also promotes their phagocytosis [<a href="#rid23">23</a>].</p><p class="headingAnchor" id="H8"><span class="h1">CLINICAL CORRELATIONS</span><span class="headingEndMark"> — </span>A number of observations indicate that dysregulated apoptosis or defective clearance of apoptotic cells may contribute to the onset or perpetuation of autoimmune disease, most likely because cells lose membrane integrity and leak their contents (post-apoptotic necrosis) [<a href="#rid1">1,24-26</a>]. There are also other mechanisms by which stimulation of the immune system by necrotic cells induce inflammation and may provoke autoimmunity [<a href="#rid1">1</a>]. These include NETosis (neutrophil extracellular trap [NET]-mediated cell death), a process by which neutrophils stimulated by certain bacteria, cytokines, or immune complexes may die; necroptosis, a form of regulated necrosis that is dependent upon receptor-interacting protein kinase 3 (RIPK3) and occurs when caspases like caspase-8 are defective; and pyroptosis, a necrotic form of macrophage death associated with the release of interleukin (IL) 1-beta [<a href="#rid1">1,26-30</a>].</p><p class="headingAnchor" id="H9"><span class="h2">Autoimmune lymphoproliferative syndrome</span><span class="headingEndMark"> — </span>The most striking example of abnormal apoptosis leading to disease is a rare autosomal dominant condition known as autoimmune lymphoproliferative syndrome (ALPS). Its onset in early childhood is heralded by lymphadenopathy, hepatosplenomegaly, and autoimmune phenomena including hemolytic anemia, thrombocytopenia, and autoimmune neutropenia, often in combination (ie, Evans syndrome). (See  <a class="medical medical_review" href="/z/d/html/16837.html" rel="external">"Autoimmune lymphoproliferative syndrome (ALPS): Clinical features and diagnosis"</a>.)</p><p>Mutations in Fas or the Fas ligand (FasL) found in these patients interfere with the elimination of activated lymphocytes following exposure to self or foreign antigens. The persistence of these cells results in expanded populations of lymphocytes and predisposes to autoimmune phenomena and to the development of lymphomas. (See  <a class="medical medical_review" href="/z/d/html/16361.html" rel="external">"Autoimmune lymphoproliferative syndrome (ALPS): Epidemiology and pathogenesis"</a>.)</p><p>Some patients require medical intervention for autoimmune manifestations, particularly clinically significant cytopenias, and usually respond to brief courses of glucocorticoids or other immunosuppressive drugs. (See  <a class="medical medical_review" href="/z/d/html/16614.html" rel="external">"Autoimmune lymphoproliferative syndrome (ALPS): Management and prognosis"</a>.)</p><p class="headingAnchor" id="H10"><span class="h2">Systemic lupus erythematosus</span><span class="headingEndMark"> — </span>Although mutant mice bearing inactivating mutations in Fas or FasL develop a clinical syndrome that resembles systemic lupus erythematosus (SLE), mutations in this death receptor pathway are only very rarely described in human SLE. Nevertheless, defective apoptosis may be involved in the activation of the immune system and production of autoantibodies reactive with self proteins, a common abnormality in those with SLE. (See  <a class="medical medical_review" href="/z/d/html/4669.html" rel="external">"Epidemiology and pathogenesis of systemic lupus erythematosus"</a>.)</p><p>A large number of spontaneous or engineered mutations in mice reveal that defective uptake of apoptotic cells predisposes to lupus-like diseases. Examples include mice deficient in opsonins such as C1q and MFG-E8, as well as mutations of receptors responsible for ingestion of apoptotic cells [<a href="#rid24">24,31</a>]. There is evidence that this process may be perturbed in some patients with SLE. Impaired phagocytosis of apoptotic cells by macrophages in the germinal centers of lymph nodes of patients has been noted [<a href="#rid25">25</a>].</p><p>Dendritic cells, which are antigen-presenting cells that migrate in search of antigen, also efficiently recognize and phagocytose apoptotic cells [<a href="#rid32">32,33</a>]. Via a poorly understood mechanism, this process allows the dendritic cells to transfer peptides derived from the digested corpse to major histocompatibility complex (MHC) molecules expressed on its cell surface. The ability of the dendritic cell to present peptides derived from other cells is known as "cross priming." By this process, antigens expressed by poorly immunogenic cells, such as tumor cells, can be presented to the immune system by a highly efficient, professional antigen-presenting cell. (See  <a class="medical medical_review" href="/z/d/html/3546.html" rel="external">"Biology of the graft-versus-tumor effect following hematopoietic cell transplantation"</a>.)</p><p>A possible adverse consequence of the ability of dendritic cells to present antigens from apoptotic cells is that self antigens may provoke an immune response (<a class="graphic graphic_figure graphicRef51145" href="/z/d/graphic/51145.html" rel="external">figure 6</a>). The immune system employs elaborate mechanisms of central and peripheral tolerance to prevent this possibility, processes that may be dysfunctional in SLE. This is supported by the observation that proteins modified by cleavage (by caspases or granzymes) or by posttranslational changes (eg, stress kinase phosphorylation, crosslinking by transglutaminase, ubiquitination and deimination of arginine residues) during cell death may be targeted by SLE autoantibodies, suggesting that dead or dying cells might serve as a reservoir of autoantigens in these patients [<a href="#rid34">34,35</a>]. Stimulation of the immune system by cells that die through necrosis, NETosis (neutrophils stimulated by certain bacteria, cytokines, or immune complexes die by this process), or necroptosis (this occurs when caspases like caspase 8 are defective and receptor interacting protein kinase 3 is activated) also cause inflammation and may provoke autoimmunity [<a href="#rid30">30,36</a>]. A common pathway for stimulation of the innate immune system is release of nucleic acids from late apoptotic cells or from necrotic cells. These nucleic acids are sensed as viruses by specialized receptors such as toll-like receptors (TLR) within phagocytic cells resulting the release of type 1 interferon and other inflammatory cytokines [<a href="#rid37">37</a>].</p><p>Abnormalities in biochemical pathways of apoptosis or in clearance of apoptotic cells in patients with SLE could be caused by genetic or environmental factors. Mutations in the genes encoding C1q and C-reactive protein (CRP), which facilitate the clearance of apoptotic cells, have been described [<a href="#rid38">38,39</a>], and genetic variations in ITGAM/CR3, which promotes the clearance of apoptotic cells [<a href="#rid21">21</a>], have been implicated in genome-wide association studies (GWAS) of SLE [<a href="#rid40">40</a>]. Because viruses typically encode antiapoptotic proteins, viral infection could delay the apoptotic program, resulting in post-apoptotic necrosis and also the accumulation of modified self peptides [<a href="#rid41">41</a>]. An example may be the viral FADD-like IL-1-beta-converting enzyme (FLICE)-inhibitory protein (FLIP), which serves as a substrate for caspase-8, thereby diverting the protease cascade and prolonging cell survival.</p><p class="headingAnchor" id="H11"><span class="h2">Rheumatoid arthritis</span><span class="headingEndMark"> — </span>Autoantibodies likely contribute to the pathophysiology of rheumatoid arthritis (RA). The presence of antibodies reactive with self immunoglobulin (ie, rheumatoid factor) and with citrullinated proteins, such as vimentin, collagen, and enolase, are sensitive markers of this disease. Citrulline results from an oxidative post-translational modification of arginine produced by peptidyl arginine deiminase (PAD), an enzyme that can be activated during apoptosis [<a href="#rid42">42</a>] but is more commonly activated by the form of programmed necrosis called NETosis [<a href="#rid29">29</a>]. Other targets of anti-citrullinated peptide antibodies (ACPA) have also been identified, and the role of these antibodies in RA is a matter of significant interest [<a href="#rid27">27,29</a>]. (See  <a class="medical medical_review" href="/z/d/html/7488.html" rel="external">"Investigational biologic markers in the diagnosis and assessment of rheumatoid arthritis", section on 'Autoantibodies'</a> and  <a class="medical medical_review" href="/z/d/html/7503.html" rel="external">"Biologic markers in the assessment of rheumatoid arthritis", section on 'Anti-citrullinated peptide antibodies'</a> and  <a class="medical medical_review" href="/z/d/html/7513.html" rel="external">"Pathogenesis of rheumatoid arthritis"</a>.)</p><p>Abnormal (reduced) apoptosis in synoviocytes or macrophages has also been proposed to contribute to the synovial proliferation that is characteristic of this disease [<a href="#rid43">43,44</a>].</p><p class="headingAnchor" id="H12"><span class="h2">Systemic sclerosis</span><span class="headingEndMark"> — </span>Endothelial cell apoptosis, mediated by antiendothelial cell antibodies and lymphocytes, has been suggested as a pathogenic mechanism in scleroderma. Examples include increased apoptosis in a chicken model of disease and the ability of sera from patients with scleroderma (plus activated lymphocytes) to induce programmed cell death in cultured human dermal endothelial cells [<a href="#rid45">45,46</a>]. Whether expression of type 1 interferon in this disease [<a href="#rid47">47,48</a>] plays a role remains to be determined. (See  <a class="medical medical_review" href="/z/d/html/7554.html" rel="external">"Pathogenesis of systemic sclerosis (scleroderma)"</a>.)</p><p class="headingAnchor" id="H95778664"><span class="h1">SUMMARY</span></p><p class="bulletIndent1"><span class="glyph">●</span>Apoptosis refers to cell death that occurs in a programmed manner, is characterized by cellular condensation, and is noninflammatory or antiinflammatory. Apoptosis plays a pivotal role in morphogenesis and tissue remodeling during embryonic development, in cell death associated with homeostasis (the billions of cells that die each day in the immune system, lungs, skin, and gastrointestinal tract), and in elimination of immune effector cells that proliferate in response to activation (eg, by microbial infection). (See <a class="local">'Introduction'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Necrotic forms of cell death may be programmed or non-programmed. Classic necrosis is not programmed; it is referred to as "accidental" or pathologic cell death and is accompanied by loss of cell membrane integrity, cell swelling, and inflammation. Programmed necrosis can result from neutrophil NETosis, a term for neutrophil extracellular trap (NET)-mediated cell death (see <a class="local">'Introduction'</a> above); from necroptosis; and from pyroptosis. Immune activation is a consequence of direct release of inflammatory cytokines from necrotic cells as well as release of nucleic acids that indirectly stimulate cytokines from phagocytes.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>In higher eukaryotes, the genetic blueprint for the core death program is complicated by the expression of multiple genes that correspond to each step regulated by just a few genes as delineated in the nematode <em>Caenorhabditis elegans</em> (<a class="graphic graphic_figure graphicRef58618" href="/z/d/graphic/58618.html" rel="external">figure 3</a>). In higher eukaryotes, the core death program can be triggered from without (external or extrinsic) by the ligation of dedicated death receptors by soluble or cell-associated ligands or from within (internal or intrinsic) the cell, when cells respond to environmental stress (eg, heat, x-rays, ultraviolet irradiation), to damage to DNA (genotoxic injury) or to misfolded proteins (<a class="graphic graphic_figure graphicRef61795" href="/z/d/graphic/61795.html" rel="external">figure 4</a>). In some cases, ligation of the dedicated death receptors (eg, CD95 [Fas]), results in the recruitment of adaptor molecules. (See <a class="local">'Molecular mechanisms of apoptosis'</a> above and <a class="local">'Caenorhabditis elegans'</a> above and <a class="local">'Higher eukaryotes'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Adaptor molecules involved in externally triggered apoptosis subsequently bind both to the cytoplasmic domain of the dedicated death receptor and to the inactive form of caspase-8, an "upstream" caspase that initiates a proteolytic cascade leading to cell death through a proteolytic cascade. In response to environmental stress or cell damage (<a class="graphic graphic_figure graphicRef60345" href="/z/d/graphic/60345.html" rel="external">figure 5</a>), members of the Bcl-2 family alter the permeability of the outer mitochondrial membrane, resulting in the release of cytochrome C and other effector proteins through several steps in the activation of caspase-9, an "upstream" caspase that is essential for initiation of the intrinsic death program with the subsequent activation of effector proteases, including caspase-3. The basic pathways that lead to apoptosis are regulated by several proteins that bind to death receptors, adaptors, or caspases to modulate their function. (See <a class="local">'Proteolytic cascade'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>One of the hallmarks of apoptosis is that cells undergoing apoptosis are normally phagocytosed by macrophages and dendritic cells without activating an inflammatory response. The efficiency of the phagocytic process depends upon the presence of the opsonins that include normal serum components, such as the complement proteins C1q, C3, and C4, and members of the pentraxin family, including pentraxin-3 (PTX3) and C-reactive protein (CRP). (See <a class="local">'Noninflammatory phagocytosis'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>A number of observations indicate that abnormal cell death may contribute to the onset or perpetuation of autoimmune disease, including autoimmune lymphoproliferative syndrome, a rare genetic condition in which mutations in Fas or Fas ligand (FasL) interfere with the elimination of activated lymphocytes following exposure to self or foreign antigens and systemic lupus erythematosus (SLE), in which defective clearance of apoptotic cells or an abnormal response to cell debris may be involved in the production of type I interferon as well as autoantibodies reactive with self proteins. Abnormal cell death or responses to cell debris may possibly also contribute to the pathogenesis of rheumatoid arthritis (RA) and systemic sclerosis. (See <a class="local">'Clinical correlations'</a> above.)</p></div><div class="headingAnchor" id="references"><ol id="reference"><li><a class="nounderline abstract_t">Elkon KB. Review: Cell Death, Nucleic Acids, and Immunity: Inflammation Beyond the Grave. Arthritis Rheumatol 2018; 70:805.</a></li><li><a class="nounderline abstract_t">Vaux DL, Korsmeyer SJ. Cell death in development. Cell 1999; 96:245.</a></li><li><a class="nounderline abstract_t">Nagata S. Apoptosis by death factor. Cell 1997; 88:355.</a></li><li><a class="nounderline abstract_t">Savill J, Dransfield I, Gregory C, Haslett C. A blast from the past: clearance of apoptotic cells regulates immune responses. Nat Rev Immunol 2002; 2:965.</a></li><li><a class="nounderline abstract_t">Erwig LP, Henson PM. Immunological consequences of apoptotic cell phagocytosis. Am J Pathol 2007; 171:2.</a></li><li><a class="nounderline abstract_t">Mizushima N, Levine B, Cuervo AM, Klionsky DJ. Autophagy fights disease through cellular self-digestion. Nature 2008; 451:1069.</a></li><li><a class="nounderline abstract_t">Horvitz HR. Genetic control of programmed cell death in the nematode Caenorhabditis elegans. Cancer Res 1999; 59:1701s.</a></li><li><a class="nounderline abstract_t">Reddien PW, Horvitz HR. The engulfment process of programmed cell death in caenorhabditis elegans. Annu Rev Cell Dev Biol 2004; 20:193.</a></li><li><a class="nounderline abstract_t">Parrish AB, Freel CD, Kornbluth S. Cellular mechanisms controlling caspase activation and function. Cold Spring Harb Perspect Biol 2013; 5.</a></li><li><a class="nounderline abstract_t">Los M, Wesselborg S, Schulze-Osthoff K. The role of caspases in development, immunity, and apoptotic signal transduction: lessons from knockout mice. Immunity 1999; 10:629.</a></li><li><a class="nounderline abstract_t">Danial NN, Korsmeyer SJ. Cell death: critical control points. Cell 2004; 116:205.</a></li><li><a class="nounderline abstract_t">Nagata S. Apoptosis and Clearance of Apoptotic Cells. Annu Rev Immunol 2018; 36:489.</a></li><li><a class="nounderline abstract_t">Newmeyer DD, Ferguson-Miller S. Mitochondria: releasing power for life and unleashing the machineries of death. Cell 2003; 112:481.</a></li><li><a class="nounderline abstract_t">Aravind L, Dixit VM, Koonin EV. The domains of death: evolution of the apoptosis machinery. Trends Biochem Sci 1999; 24:47.</a></li><li><a class="nounderline abstract_t">Peter ME, Krammer PH. The CD95(APO-1/Fas) DISC and beyond. Cell Death Differ 2003; 10:26.</a></li><li><a class="nounderline abstract_t">Ashkenazi A, Dixit VM. Apoptosis control by death and decoy receptors. Curr Opin Cell Biol 1999; 11:255.</a></li><li><a class="nounderline abstract_t">Cory S, Huang DC, Adams JM. The Bcl-2 family: roles in cell survival and oncogenesis. Oncogene 2003; 22:8590.</a></li><li><a class="nounderline abstract_t">Youle RJ, Strasser A. The BCL-2 protein family: opposing activities that mediate cell death. Nat Rev Mol Cell Biol 2008; 9:47.</a></li><li><a class="nounderline abstract_t">Riedl SJ, Shi Y. Molecular mechanisms of caspase regulation during apoptosis. Nat Rev Mol Cell Biol 2004; 5:897.</a></li><li><a class="nounderline abstract_t">Downward J. PI 3-kinase, Akt and cell survival. Semin Cell Dev Biol 2004; 15:177.</a></li><li><a class="nounderline abstract_t">Mevorach D, Mascarenhas JO, Gershov D, Elkon KB. Complement-dependent clearance of apoptotic cells by human macrophages. J Exp Med 1998; 188:2313.</a></li><li><a class="nounderline abstract_t">Gershov D, Kim S, Brot N, Elkon KB. C-Reactive protein binds to apoptotic cells, protects the cells from assembly of the terminal complement components, and sustains an antiinflammatory innate immune response: implications for systemic autoimmunity. J Exp Med 2000; 192:1353.</a></li><li><a class="nounderline abstract_t">Anderson HA, Maylock CA, Williams JA, et al. Serum-derived protein S binds to phosphatidylserine and stimulates the phagocytosis of apoptotic cells. Nat Immunol 2003; 4:87.</a></li><li><a class="nounderline abstract_t">Nagata S, Hanayama R, Kawane K. Autoimmunity and the clearance of dead cells. Cell 2010; 140:619.</a></li><li><a class="nounderline abstract_t">Baumann I, Kolowos W, Voll RE, et al. Impaired uptake of apoptotic cells into tingible body macrophages in germinal centers of patients with systemic lupus erythematosus. Arthritis Rheum 2002; 46:191.</a></li><li class="breakAll">Elkon KB, Oberst A. Apoptosis and inflammatory forms of cell death. In: Dubois' Lupus Erythematosus and Related Syndromes, 9th ed, Wallace DJ, Hahn BH (Eds), Elsevier, 2018. p.237.</li><li><a class="nounderline abstract_t">Dwivedi N, Radic M. Citrullination of autoantigens implicates NETosis in the induction of autoimmunity. Ann Rheum Dis 2014; 73:483.</a></li><li><a class="nounderline abstract_t">Linkermann A, Green DR. Necroptosis. N Engl J Med 2014; 370:455.</a></li><li><a class="nounderline abstract_t">Khandpur R, Carmona-Rivera C, Vivekanandan-Giri A, et al. NETs are a source of citrullinated autoantigens and stimulate inflammatory responses in rheumatoid arthritis. Sci Transl Med 2013; 5:178ra40.</a></li><li><a class="nounderline abstract_t">Lood C, Blanco LP, Purmalek MM, et al. Neutrophil extracellular traps enriched in oxidized mitochondrial DNA are interferogenic and contribute to lupus-like disease. Nat Med 2016; 22:146.</a></li><li><a class="nounderline abstract_t">Bergsbaken T, Fink SL, Cookson BT. Pyroptosis: host cell death and inflammation. Nat Rev Microbiol 2009; 7:99.</a></li><li><a class="nounderline abstract_t">Albert ML, Sauter B, Bhardwaj N. Dendritic cells acquire antigen from apoptotic cells and induce class I-restricted CTLs. Nature 1998; 392:86.</a></li><li><a class="nounderline abstract_t">Ganguly D, Haak S, Sisirak V, Reizis B. The role of dendritic cells in autoimmunity. Nat Rev Immunol 2013; 13:566.</a></li><li><a class="nounderline abstract_t">Utz PJ, Anderson P. Posttranslational protein modifications, apoptosis, and the bypass of tolerance to autoantigens. Arthritis Rheum 1998; 41:1152.</a></li><li><a class="nounderline abstract_t">Hall JC, Casciola-Rosen L, Rosen A. Altered structure of autoantigens during apoptosis. Rheum Dis Clin North Am 2004; 30:455.</a></li><li><a class="nounderline abstract_t">Guo C, Fu R, Zhou M, et al. Pathogenesis of lupus nephritis: RIP3 dependent necroptosis and NLRP3 inflammasome activation. J Autoimmun 2019; 103:102286.</a></li><li><a class="nounderline abstract_t">Barrat FJ, Elkon KB, Fitzgerald KA. Importance of Nucleic Acid Recognition in Inflammation and Autoimmunity. Annu Rev Med 2016; 67:323.</a></li><li><a class="nounderline abstract_t">Russell AI, Cunninghame Graham DS, Shepherd C, et al. Polymorphism at the C-reactive protein locus influences gene expression and predisposes to systemic lupus erythematosus. Hum Mol Genet 2004; 13:137.</a></li><li><a class="nounderline abstract_t">Manderson AP, Botto M, Walport MJ. The role of complement in the development of systemic lupus erythematosus. Annu Rev Immunol 2004; 22:431.</a></li><li><a class="nounderline abstract_t">International Consortium for Systemic Lupus Erythematosus Genetics (SLEGEN), Harley JB, Alarcón-Riquelme ME, et al. Genome-wide association scan in women with systemic lupus erythematosus identifies susceptibility variants in ITGAM, PXK, KIAA1542 and other loci. Nat Genet 2008; 40:204.</a></li><li><a class="nounderline abstract_t">Granville DJ, Carthy CM, Yang D, et al. Interaction of viral proteins with host cell death machinery. Cell Death Differ 1998; 5:653.</a></li><li><a class="nounderline abstract_t">van Venrooij WJ, van Beers JJ, Pruijn GJ. Anti-CCP Antibody, a Marker for the Early Detection of Rheumatoid Arthritis. Ann N Y Acad Sci 2008; 1143:268.</a></li><li><a class="nounderline abstract_t">Kobayashi T, Okamoto K, Kobata T, et al. Apomodulation as a novel therapeutic concept for the regulation of apoptosis in rheumatoid synoviocytes. Curr Opin Rheumatol 1999; 11:188.</a></li><li><a class="nounderline abstract_t">Scatizzi JC, Hutcheson J, Pope RM, et al. Bim-Bcl-2 homology 3 mimetic therapy is effective at suppressing inflammatory arthritis through the activation of myeloid cell apoptosis. Arthritis Rheum 2010; 62:441.</a></li><li><a class="nounderline abstract_t">Sgonc R, Gruschwitz MS, Dietrich H, et al. Endothelial cell apoptosis is a primary pathogenetic event underlying skin lesions in avian and human scleroderma. J Clin Invest 1996; 98:785.</a></li><li><a class="nounderline abstract_t">Sgonc R, Gruschwitz MS, Boeck G, et al. Endothelial cell apoptosis in systemic sclerosis is induced by antibody-dependent cell-mediated cytotoxicity via CD95. Arthritis Rheum 2000; 43:2550.</a></li><li><a class="nounderline abstract_t">Tan FK, Zhou X, Mayes MD, et al. Signatures of differentially regulated interferon gene expression and vasculotrophism in the peripheral blood cells of systemic sclerosis patients. Rheumatology (Oxford) 2006; 45:694.</a></li><li><a class="nounderline abstract_t">Duan H, Fleming J, Pritchard DK, et al. Combined analysis of monocyte and lymphocyte messenger RNA expression with serum protein profiles in patients with scleroderma. Arthritis Rheum 2008; 58:1465.</a></li></ol></div><div id="topicVersionRevision">Topic 5594 Version 24.0</div></div>
<div class="row">
<div class="col-12">
<h4 style="text-align: center;padding: 20px;color: cadetblue;">References</h4>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/29439290" id="rid0" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>1 : Review: Cell Death, Nucleic Acids, and Immunity: Inflammation Beyond the Grave.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9988219" id="rid1" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>2 : Cell death in development.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9039262" id="rid2" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>3 : Apoptosis by death factor.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12461569" id="rid3" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>4 : A blast from the past: clearance of apoptotic cells regulates immune responses.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17591947" id="rid4" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>5 : Immunological consequences of apoptotic cell phagocytosis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/18305538" id="rid5" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>6 : Autophagy fights disease through cellular self-digestion.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10197583" id="rid6" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>7 : Genetic control of programmed cell death in the nematode Caenorhabditis elegans.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15473839" id="rid7" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>8 : The engulfment process of programmed cell death in caenorhabditis elegans.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23732469" id="rid8" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>9 : Cellular mechanisms controlling caspase activation and function.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10403638" id="rid9" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>10 : The role of caspases in development, immunity, and apoptotic signal transduction: lessons from knockout mice.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/14744432" id="rid10" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>11 : Cell death: critical control points.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/29400998" id="rid11" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>12 : Apoptosis and Clearance of Apoptotic Cells.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12600312" id="rid12" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>13 : Mitochondria: releasing power for life and unleashing the machineries of death.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10098397" id="rid13" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>14 : The domains of death: evolution of the apoptosis machinery.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12655293" id="rid14" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>15 : The CD95(APO-1/Fas) DISC and beyond.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10209153" id="rid15" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>16 : Apoptosis control by death and decoy receptors.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/14634621" id="rid16" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>17 : The Bcl-2 family: roles in cell survival and oncogenesis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/18097445" id="rid17" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>18 : The BCL-2 protein family: opposing activities that mediate cell death.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15520809" id="rid18" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>19 : Molecular mechanisms of caspase regulation during apoptosis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15209377" id="rid19" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>20 : PI 3-kinase, Akt and cell survival.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9858517" id="rid20" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>21 : Complement-dependent clearance of apoptotic cells by human macrophages.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11067883" id="rid21" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>22 : C-Reactive protein binds to apoptotic cells, protects the cells from assembly of the terminal complement components, and sustains an antiinflammatory innate immune response: implications for systemic autoimmunity.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12447359" id="rid22" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>23 : Serum-derived protein S binds to phosphatidylserine and stimulates the phagocytosis of apoptotic cells.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/20211132" id="rid23" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>24 : Autoimmunity and the clearance of dead cells.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11817590" id="rid24" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>25 : Impaired uptake of apoptotic cells into tingible body macrophages in germinal centers of patients with systemic lupus erythematosus.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11817590" id="rid25" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>26 : Impaired uptake of apoptotic cells into tingible body macrophages in germinal centers of patients with systemic lupus erythematosus.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/24291655" id="rid26" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>27 : Citrullination of autoantigens implicates NETosis in the induction of autoimmunity.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/24476434" id="rid27" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>28 : Necroptosis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23536012" id="rid28" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>29 : NETs are a source of citrullinated autoantigens and stimulate inflammatory responses in rheumatoid arthritis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/26779811" id="rid29" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>30 : Neutrophil extracellular traps enriched in oxidized mitochondrial DNA are interferogenic and contribute to lupus-like disease.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19148178" id="rid30" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>31 : Pyroptosis: host cell death and inflammation.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9510252" id="rid31" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>32 : Dendritic cells acquire antigen from apoptotic cells and induce class I-restricted CTLs.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23827956" id="rid32" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>33 : The role of dendritic cells in autoimmunity.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9663470" id="rid33" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>34 : Posttranslational protein modifications, apoptosis, and the bypass of tolerance to autoantigens.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15261336" id="rid34" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>35 : Altered structure of autoantigens during apoptosis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/31133359" id="rid35" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>36 : Pathogenesis of lupus nephritis: RIP3 dependent necroptosis and NLRP3 inflammasome activation.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/26526766" id="rid36" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>37 : Importance of Nucleic Acid Recognition in Inflammation and Autoimmunity.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/14645206" id="rid37" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>38 : Polymorphism at the C-reactive protein locus influences gene expression and predisposes to systemic lupus erythematosus.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15032584" id="rid38" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>39 : The role of complement in the development of systemic lupus erythematosus.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/18204446" id="rid39" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>40 : Genome-wide association scan in women with systemic lupus erythematosus identifies susceptibility variants in ITGAM, PXK, KIAA1542 and other loci.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10200520" id="rid40" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>41 : Interaction of viral proteins with host cell death machinery.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19076355" id="rid41" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>42 : Anti-CCP Antibody, a Marker for the Early Detection of Rheumatoid Arthritis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10328578" id="rid42" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>43 : Apomodulation as a novel therapeutic concept for the regulation of apoptosis in rheumatoid synoviocytes.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/20112357" id="rid43" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>44 : Bim-Bcl-2 homology 3 mimetic therapy is effective at suppressing inflammatory arthritis through the activation of myeloid cell apoptosis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8698871" id="rid44" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>45 : Endothelial cell apoptosis is a primary pathogenetic event underlying skin lesions in avian and human scleroderma.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11083280" id="rid45" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>46 : Endothelial cell apoptosis in systemic sclerosis is induced by antibody-dependent cell-mediated cytotoxicity via CD95.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16418202" id="rid46" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>47 : Signatures of differentially regulated interferon gene expression and vasculotrophism in the peripheral blood cells of systemic sclerosis patients.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/18438864" id="rid47" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>48 : Combined analysis of monocyte and lymphocyte messenger RNA expression with serum protein profiles in patients with scleroderma.</p>
</a>
</div>
</div>
</div>
</div>
</section>
</section>
<!-- End Main Menu Area -->
<!-- Start Search Popup Area -->
<!-- End Footer Area -->
<!-- Back to top -->
<a class="scrolltop" href="#top"><i class="icofont-hand-drawn-up"></i></a>
<!-- End Back to top -->
<!-- jQuery Min JS -->
<!-- Prpper JS -->
<!-- Bootstrap Min JS -->
<!-- Classy Nav Min Js -->
<!-- Owl Carousel Min Js -->
<!-- Magnific Popup JS -->
<!-- CounterUp JS -->
<!-- Waypoints JS -->
<!-- Form Validator Min JS -->
<!-- Contact Form Min JS -->
<!-- Main JS -->
<!-- Global site tag (gtag.js) - Google Analytics -->
</body>
</html>
